Educational level, management and outcomes in small-cell lung cancer (SCLC): a population-based cohort study

Small cell lung cancer (SCLC) represents 13% of all newly diagnosed cases of lung cancer (LC) worldwide [1]. SCLC is a tumour that typically appears in heavy smokers, with 95% of SCLC patients being current or former smokers [2]. The incidence rate of SCLC has slightly decreased globally since the early 1990s, reflecting a general decrease in smoking habits [3]. The prognosis of SCLC is generally quite poor, with a median survival of 14-16 months for patients with Limited Disease (LD) and 8-11 months for those with Extensive Disease (ED).

Source: Lung Cancer - November 13, 2019 Category: Cancer & Oncology Authors: Salomon Tendler, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn, Mats Lambe, Luigi De Petris Source Type: research